-
1دورية أكاديمية
المؤلفون: Krueger, James G., Eyerich, Kilian, Kuchroo, Vijay K., Ritchlin, Christopher T., Abreu, Maria T., Elloso, M. Merle, Fourie, Anne, Fakharzadeh, Steven, Sherlock, Jonathan P., Yang, Ya-Wen, Cua, Daniel J., McInnes, Iain B.
وصف الملف: text
العلاقة: https://eprints.gla.ac.uk/326004/1/326004.pdfTest; Krueger, J. G. et al. (2024) IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy. Frontiers in Immunology , 15, 1331217. (doi:10.3389/fimmu.2024.1331217 ) (PMID:38686385) (PMCID:PMC11056518)
-
2دورية أكاديمية
المؤلفون: Coates, Laura, C, Landewé, Robert, Mcinnes, Iain, B, Mease, Philip, J, Ritchlin, Christopher, T, Tanaka, Yoshiya, Asahina, Akihiko, Behrens, Frank, Gladman, Dafna, D, Gossec, Laure, Orbai, Ana-Maria, Gottlieb, Alice, B, Warren, Richard, B, Ink, Barbara, Bajracharya, Rajan, Shende, Vishvesh, Coarse, Jason, Merola, Joseph, F
المساهمون: Pharmacoépidémiologie et évaluation des soins iPLesp (PEPITES), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
المصدر: EISSN: 2056-5933 ; RMD Open ; https://hal.science/hal-04564137Test ; RMD Open, 2024, 10 (1), pp.e003855. ⟨10.1136/rmdopen-2023-003855⟩
مصطلحات موضوعية: arthritis, psoriatic, biological therapy, tumor necrosis factor inhibitors, [SDV]Life Sciences [q-bio]
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38388171; hal-04564137; https://hal.science/hal-04564137Test; https://hal.science/hal-04564137/documentTest; https://hal.science/hal-04564137/file/2024%20Coates%20RMD%20Open%20bimekizumab%2052%20weeks.pdfTest; PUBMED: 38388171; PUBMEDCENTRAL: PMC10884206
الإتاحة: https://doi.org/10.1136/rmdopen-2023-003855Test
https://hal.science/hal-04564137Test
https://hal.science/hal-04564137/documentTest
https://hal.science/hal-04564137/file/2024%20Coates%20RMD%20Open%20bimekizumab%2052%20weeks.pdfTest -
3دورية أكاديمية
المؤلفون: Furuya, Hiroki, Nguyen, Cuong Thach, Chan, Trevor, Marusina, Alina I., Merleev, Alexander A., Garcia-Hernandez, Maria de la Luz, Hsieh, Shie-Liang, Tsokos, George C., Ritchlin, Christopher T., Tagkopoulos, Ilias, Maverakis, Emanual, Adamopoulos, Iannis E.
المساهمون: National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Psoriasis Foundation
المصدر: Journal of Autoimmunity ; volume 143, page 103167 ; ISSN 0896-8411
مصطلحات موضوعية: Immunology, Immunology and Allergy
الإتاحة: https://doi.org/10.1016/j.jaut.2024.103167Test
https://api.elsevier.com/content/article/PII:S0896841124000015?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0896841124000015?httpAccept=text/plainTest -
4دورية أكاديمية
المؤلفون: Ritchlin, Christopher T., Deodhar, Atul, Boehncke, Wolf‐Henning, Soriano, Enrique R., Kollmeier, Alexa P., Xu, Xie L., Zazzetti, Federico, Shawi, May, Jiang, Yusang, Sheng, Shihong, Helliwell, Philip S.
المصدر: ACR Open Rheumatology ; volume 5, issue 3, page 149-164 ; ISSN 2578-5745 2578-5745
-
5دورية أكاديمية
المؤلفون: McGonagle, Dennis, McInnes, Iain B., Deodhar, Atul, Schett, Georg, Shawi, May, Chakravarty, Soumya D., Kollmeier, Alexa P., Xu, Xie L., Sheng, Shihong, Xu, Stephen, Ritchlin, Christopher T., Rahman, Proton, Mease, Phillip J.
المساهمون: Janssen Research and Development
المصدر: ACR Open Rheumatology ; volume 5, issue 4, page 227-240 ; ISSN 2578-5745 2578-5745
-
6دورية أكاديمية
المؤلفون: Ritchlin, Christopher T, Deodhar, Atul, Boehncke, Wolf-Henning, Soriano, Enrique R, Kollmeier, Alexa P, Xu, Xie L, Zazzetti, Federico, Shawi, May, Jiang, Yusang, Sheng, Shihong, Helliwell, Philip S
المصدر: ISSN: 2578-5745 ; ACR open rheumatology, vol. 5, no. 3 (2023) p. 149-164.
مصطلحات موضوعية: info:eu-repo/classification/ddc/616
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36762512; https://archive-ouverte.unige.ch/unige:176221Test; unige:176221
-
7دورية أكاديمية
المؤلفون: Merola, Joseph F., Landewé, Robert, McInnes, Iain B., Mease, Philip J., Ritchlin, Christopher T., Tanaka, Yoshiya, Asahina, Akihiko, Behrens, Frank, Gladman, Dafna D., Fossec, Laure, Gottlieb, Alice B., Thaçi, Diamant, Warren, Richard B., Ink, Barbara, Assudani, Deepak, Bajracharya, Rajan, Shende, Vishvesh, Coarse, Jason, Coates, Laura C.
وصف الملف: text
العلاقة: https://eprints.gla.ac.uk/286276/1/286276.pdfTest; Merola, J. F. et al. (2023) Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE). Lancet , 401(10370), pp. 38-48. (doi:10.1016/S0140-6736(22)02303-0 ) (PMID:36495881)
-
8دورية أكاديمية
المؤلفون: McInnes, Iain B., Asahina, Akihiko, Coates, Laura C., Landewé, Robert, Merola, Joseph F., Ritchlin, Christopher T., Tanaka, Yoshiya, Gossec, Laure, Gottlieb, Alice B., Warren, Richard B., Ink, Barbara, Assudani, Deepak, Bajracharya, Rajan, Shende, Vishvesh, Coarse, Jason, Mease, Philip J.
وصف الملف: text
العلاقة: https://eprints.gla.ac.uk/286275/1/286275.pdfTest; McInnes, I. B. et al. (2023) Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL). Lancet , 401(10370), pp. 25-37. (doi:10.1016/S0140-6736(22)02302-9 ) (PMID:36493791)
-
9دورية أكاديمية
المؤلفون: Mcinnes, Iain, B, Asahina, Akihiko, Coates, Laura, C, Landewé, Robert, Merola, Joseph, F, Ritchlin, Christopher, T, Tanaka, Yoshiya, Gossec, Laure, Gottlieb, Alice, B, Warren, Richard, B, Ink, Barbara, Assudani, Deepak, Bajracharya, Rajan, Shende, Vishvesh, Coarse, Jason, Mease, Philip, J
المساهمون: Pharmacoépidémiologie et évaluation des soins iPLesp (PEPITES), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
المصدر: ISSN: 0140-6736.
مصطلحات موضوعية: [SDV]Life Sciences [q-bio]
العلاقة: hal-03958098; https://hal.science/hal-03958098Test; https://hal.science/hal-03958098/documentTest; https://hal.science/hal-03958098/file/2022%20McInnes%20Lancet%20bimekizumab%20BeOptimal.pdfTest
الإتاحة: https://doi.org/10.1016/S0140-6736Test(22)02302-9
https://hal.science/hal-03958098Test
https://hal.science/hal-03958098/documentTest
https://hal.science/hal-03958098/file/2022%20McInnes%20Lancet%20bimekizumab%20BeOptimal.pdfTest -
10دورية أكاديمية
المؤلفون: Merola, Joseph, F, Landewé, Robert, Mcinnes, Iain, B, Mease, Philip, J, Ritchlin, Christopher, T, Tanaka, Yoshiya, Asahina, Akihiko, Behrens, Frank, Gladman, Dafna, D, Gossec, Laure, Gottlieb, Alice, B, Thaçi, Diamant, Warren, Richard, B, Ink, Barbara, Assudani, Deepak, Bajracharya, Rajan, Shende, Vishvesh, Coarse, Jason, Coates, Laura, C
المساهمون: Pharmacoépidémiologie et évaluation des soins iPLesp (PEPITES), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
المصدر: ISSN: 0140-6736.
مصطلحات موضوعية: [SDV]Life Sciences [q-bio]
العلاقة: hal-03958064; https://hal.science/hal-03958064Test; https://hal.science/hal-03958064/documentTest; https://hal.science/hal-03958064/file/2023%20Merola%20Lancet%20bimekizumab%20BeComplete.pdfTest
الإتاحة: https://doi.org/10.1016/S0140-6736Test(22)02303-0
https://hal.science/hal-03958064Test
https://hal.science/hal-03958064/documentTest
https://hal.science/hal-03958064/file/2023%20Merola%20Lancet%20bimekizumab%20BeComplete.pdfTest